Futurum principal analyst Daniel Newman discusses how Congress coming to an impasse with the proposed CHIPS Act may set Intel back nearly $100 billion as the development of their new U.S.-based semiconductor manufacturer could come to a pause.
Futurum principal analyst Daniel Newman discusses how Congress coming to an impasse with the proposed CHIPS Act may set Intel back nearly $100 billion as the development of their new U.S.-based semiconductor manufacturer could come to a pause.